2009
DOI: 10.1093/toxsci/kfp242
|View full text |Cite
|
Sign up to set email alerts
|

In Utero Exposure to Benzene Disrupts Fetal Hematopoietic Progenitor Cell Growth via Reactive Oxygen Species

Abstract: It is hypothesized that the increasing incidence of childhood leukemia may be due to in utero exposure to environmental pollutants, such as benzene, but the mechanisms involved remain unknown. We hypothesize that reactive oxygen species (ROS) contribute to the deregulation of fetal hematopoiesis caused by in utero benzene exposure. To evaluate this hypothesis, pregnant C57Bl/6N mice were exposed to benzene or polyethylene glycol-conjugated catalase (PEG-catalase) (antioxidative enzyme) and benzene. Colony form… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
29
0
1

Year Published

2012
2012
2020
2020

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 55 publications
(32 citation statements)
references
References 41 publications
2
29
0
1
Order By: Relevance
“…Once absorbed, CYA is extensively metabolized in the liver and intestine, producing a number of metabolites, with BDCYA (1,4-bisdesoxycyadox) being the main metabolite and designated as the marker residue in some jurisdictions (Liu et al, 2009;Xu et al, 2012;Wu et al, 2012). BDCYA, the N-oxide reduction product of CYA, is formed by reducing oxygen on both the N1 and N4 sites on the benzene moiety which would lead to DNA damage by intermediate radical production Badham et al, 2010). Hence, BDCYA could be a potential toxic metabolite of CYA, and should be considered together with the parent drug for food safety concerns.…”
Section: Introductionmentioning
confidence: 99%
“…Once absorbed, CYA is extensively metabolized in the liver and intestine, producing a number of metabolites, with BDCYA (1,4-bisdesoxycyadox) being the main metabolite and designated as the marker residue in some jurisdictions (Liu et al, 2009;Xu et al, 2012;Wu et al, 2012). BDCYA, the N-oxide reduction product of CYA, is formed by reducing oxygen on both the N1 and N4 sites on the benzene moiety which would lead to DNA damage by intermediate radical production Badham et al, 2010). Hence, BDCYA could be a potential toxic metabolite of CYA, and should be considered together with the parent drug for food safety concerns.…”
Section: Introductionmentioning
confidence: 99%
“…reduced numbers of bone marrow cells, erythrocytes and lymphocytes) have been reported in 4 in vivo benzene studies Farris et al, 1997;Niculescu & Kalf, 1995;Robinson et al, 1997). Lastly, oxidative stress such as ROS generation (Badham & Winn, 2010b;Kolachana et al, 1993), nitrosative stress such as nitric oxide generation (Chen et al, 2005b;Laskin et al, 1995;Punjabi et al, 1994) have been mentioned to contribute to the benzene-mediated haematotoxicity.…”
Section: Supporting Publications 2016: En-955 130mentioning
confidence: 98%
“…The European Food Safety Authority reserves its rights, view and position as regards the issues addressed and the conclusions reached in the present document, without prejudice to the rights of the authors. Winn, 2010aWinn, , 2010bLau et al, 2009). For inhalation studies, a range of 10-400 ppm has been used for subchronic/chronic exposure studies (i.e.…”
Section: Supporting Publications 2016: En-955 130mentioning
confidence: 99%
See 1 more Smart Citation
“…The cellular redox status and antioxidant defense mechanisms are more sensitive and lower in the embryo compared to adults [9][10][11][12][13]. Antioxidant defense mechanisms against free radical-induced oxidative damage include the following (i) catalytic removal of free radicals and reactive species by factors such as CAT, SOD, peroxidase and thiol-specific antioxidants; (ii) binding of proteins (e.g., transferrin, metallothionein, haptoglobins, ceruloplasmin) to pro-oxidant metal ions, such as iron and copper; (iii) protection against macromolecular damage by proteins such as stress or heat shock proteins; and (iv) reduction of free radicals by electron donors, such as GSH, vitamin E, vitamin C, bilirubin and uric acid [14][15][16][17][18][19][20].…”
Section: Introductionmentioning
confidence: 99%